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ABSTRACT
AGE-ASSOCIATED CHANGES IN INNATE IMMUNITY AND THEIR IMPACTS
ON INFLAMMATORY DISEASES

Mehmet Akif Eskan DDS
November 3, 2011
Periodontal disease arises from excessive host inflammatory responses to
the tooth-associated microbial biofilm, known as dental plaque. Severity ranges
from superficial inflammation of the gingivae (gingivitis) to extensive destruction
of connective tissue and bone (periodontitis) leading to tooth loss. In its severe
form, periodontitis affects 10 - 15% of the total human population to the extent
that they will lose half their teeth by age 50. Periodontitis, a prevalent chronic
disease with an impact on systemic health, such as atherosclerosis and
Alzheimer's disease, is critically dependent on neutrophils. Although conventional
periodontal treatment may reverse destructive inflammation, a subset of patients
develops recurrent disease for reasons that are not clear, thus necessitating
better understanding of the underlying immunopathology. Therefore, there is a
compelling need to elucidate pathogenic mechanisms, which may be targeted for
novel therapeutic intervention strategies in periodontal disease.
Developmental endothelial locus-1 (Del-1) was recently identified as a
novel endothelial-derived inhibitor of neutrophil extravasation. However, whether

v

Oel-1 regulates the local tissue-specific inflammatory response and controls
chronic inflammatory diseases has not been addressed yet. Upon aging, normal
mice displayed increased disease accompanied by diminished Oel-1 expression.
Consistent with a protective role for Oel-1 in periodontitis, Del-1-1- mice developed
spontaneous inflammatory periodontal bone loss characterized by excessive
local neutrophil infiltration and interleukin (IL)-17 expression. The disease was
reversed in Del-1-1- mice with additional genetic deficiencies in the LFA-1 integrin
or the IL-17 receptor. Strikingly, local administration of Oel-1 suppressed
neutrophil infiltration and IL-17 expression in the periodontal tissue. We,
therefore, concluded that Oel-1 is required for tissue homeostasis by regulating
LFA-1-dependent neutrophil trafficking, inhibiting IL-17-mediated pathology, and
may be a promising novel therapeutic for the treatment of inflammatory diseases.
In conclusion, we showed that Oel-1, a novel inhibitor of integrindependent neutrophil adhesion, regulates local tissue-specific inflammation and
controls chronic inflammatory disease. Oel-1 inhibits LFA-1-dependent neutrophil
recruitment and IL-17-mediated pathology and may be a promising novel
therapeutic for inflammatory diseases.
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1. INTRODUCTION
Aging and Inflammation

The elderly population is increasing. According to the US Bureau of the
Census, in 1997, 1 in 8 Americans were over 65 years old and it is expected that
1 in 5 Americans will be elderly by 2030 (Figure 1). Age is usually considered as
a risk factor for increased inflammation and impaired wound healing [1].
Physiological loss of periodontal attachment and alveolar bone is seen in the
elderly and is normally of little clinical significance. However, these changes can
become severe in the presence of concomitant periodontal inflammation as an
individual ages [2, 3]. This is consistent with the inflammatory etiology of
periodontal disease, where tissue damage is primarily caused by excessive host
inflammatory reactions to subgingival gram-negative anaerobic pathogens [4].
Conversely, it may be argued that the increased severity of periodontitis in old
age could be simply the cumulative effect of prolonged exposure to microbial
challenge.

While this might be a contributory factor, several observations

support the significance of age-related alterations in the periodontal immune
response.

In an experimental gingivitis study involving young (20-25 years of

age) and elderly

(~

65 years) individuals, all subjects received professional dental

care to establish healthy gingival starting conditions and, subsequently,
abstained from oral hygiene. Although young and old subjects displayed

1

comparable dental plaque biofilm accumulation, the latter group developed more
severe gingivitis associated with elevated numbers of inflammatory cells [5]
indicating that the periodontal innate immune response is influenced by age.

2

Growth of the Elderly Population
80
70.3

70

60

53.7

~ 50
39.7

.2 40

:i

34.4 34.8

30

20
10
O~~~~~~~~~~~~~~

~~

,,OJ

~

,,~

~~

"OJ

fo~

,,OJ

9J~

"OJ

!J)tQ

~~

,,OJ ~

,,~

~

fI,~

~~

!'J~

~

Years
(Source: U.S. Bureau of the Census)

Figure 1. The percentage of elderly is increasing in USA. This shows that the
elderly population is increasing in USA.

3

The elderly are at increased risk for microbial infection leading to chronic
inflammation and malignancy [6, 7]. Individuals are not equally affected by the
accumulation of bacterial plaque around their teeth. Very susceptible subjects
will develop aggressive forms of periodontitis at a relatively young age whereas
others may never develop periodontitis [8].

Most of the population fall

somewhere between these extremes. This might be explained by that monocytes
that were carrying different human leukocyte antigen (HLA) harvested from
different subjects. Those monocytes responded differently to LPS stimulation
with production of pro-inflammatory cytokines, including interlukin 1, tumor
necrosis factor alpha or prostaglandin E2, supporting a genetically determined
basis for inflammatory disorders [9].

Shapira et al. [10] suggested that inter-

individual differences in monocyte/macrophage responses can be found in
periodontitis patients compared to healthy subjects [10, 11]. As humans age,
they encounter more disease and most of these diseases are due to declines of
cellular function, affecting all cell types to different extents.

Impaired wound

healing in the elderly presents a major clinical and economic problem. With the
aging population growing in both number and percentage, the importance of
understanding the mechanisms underlying age-related impairments in healing
increases.

Normal periodontal tissues exhibit characteristic changes with age

that have implications for wound healing [12]. It also has been reported that
periodontal attachment loss and gingival recession showed an increase by age
[13, 14]. All together, efficient cell function enhances wound healing and limits
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chronic disease and any functional decline in these processes are important
health concerns for the elderly.
More than three decades ago, Page and Schroeder reported that
polymorphonuclear neutrophils (PMNs) play an important role in periodontal
disease progression [15]. It has been consistently reported that periodontally
diseased gingiva are abundant with primed and hyperactivated neutrophils
releasing oxygen radicals, cytokines and chemokines [16]. Neutrophils might play
an important role during the transition from gingivitis to periodontitis. In fact, the
concept of a primed or hyperactive neutrophil in chronic [17, 18] or aggressive
periodontitis [19] has begun to emerge, leading to a new perspective on the role
of neutrohils in periodontitis. They are considered scavenging phagocytes, which
clear microbes, play a major role in the control of infections by intracellular
pathogens and modulate the immune system [20]. In addition to neutrophils, for
example, interleukin-17 (IL-17) has been reported to be involved in chronic
inflammatory diseases [21,22].

5

------~

Neutrophils and IL-17

Recently, it has been shown that interleukin-17 (also known as IL-17A) is
a key cytokine regulating the infiltration of neutrophils into tissues [23].
Specifically, IL-17A has been reported to regulate neutrophil mobilization by
promoting granulopoiesis, [24, 25]. Moreover, IL-17 has been shown to
orchestrates activation of neutrophils during inflammation [26, 27]. IL-17 was also
shown to induce the activations and survival of neutrophils [26-28].
The interleukin-17 (IL-17) family, IL-17A to IL-17F, is emerging as major
players in immune responses and inflammatory diseases [29]. These cytokines
mediate their biological functions through the IL-17 receptor family, IL-17RA to
IL-17RE [30]. 50% of the IL-17A and IL-17F structure is identical (Figure 2),
accounting for their sharing several biological properties [30]. It has been well
documented that several cell types, such as T cells, neutrophils, and
macrophages, express IL-17A and IL-17F [22, 30, 31]. Tissue mediated innate
immunity can be promoted by IL-17A and IL-17F by inducing pro-inflammatory
responses.

IL-17 target molecules include chemokines (CXCL 1, CXCL8,

CXCL 10), cytokines (TNF-a, IL-1, IL-6, and GM-CSF) and acute/delayed-phase
responses (RANKL) [24]. Furthermore, it has been reported that the combined
action of IL-17A or IL-17F with other cytokines including, TNF-a,

IL-1~

and IFN-y

synergistically augments the induction of pro-inflammatory responses [32, 33].
Consistently, IL-17 A has been implicated in bone resorption in mouse models of
arthritis [34] and the absence of IL-17A expression reduced disease activity in
rheumatoid arthritis [22, 35]. Parallel to these studies, neutrophils and IL-17A

6

interaction has been reported to induce myocarditis and/or myocardial infarction
following experimental bacteremia of Porphyromonas gingiva/is in mice [36].
Together, it is becoming clear that there is a strong interaction between IL-17 and
neutrophil function.
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Del-1 and Neutrophils

In response to tissue infection, leukocytes extravasate into peripheral
tissues and attempt to kill pathogenic microorganisms. In this regard, and in the
context of periodontitis, PMNs form a first line of defense and promptly migrate to
the gingival crevice in response to the tooth-associated pathogenic biofilm [37].
PMNs attempt to kill the invading microbes by releasing the toxic contents of their
granules including reactive oxygen species (ROS) and reactive nitrogen species,
proteinase 3, cathepsin-G and elastase [38]. These highly potent effectors do not
discriminate between microbial and host cells, and may result in collateral
damage to the host tissues [39]. Because neutrophils display a large array of
microbicidal and proinflammatory mechanisms that are potentially harmful to the
host, their activation and trafficking is tightly regulated [40-43]. Therefore, tight
regulation of PMN recruitment is important for preventing excessive influx and
unwarranted inflammation. Inflammatory cell recruitment happens in the three
steps involving rolling, activation and adhesion [44]. PMN recruitment to inflamed
tissue is regulated by selectins that facilitate cell rolling and activation of 132
integrins (CD11/CD18) which in turn mediate stable adhesion and migration
across the blood vessel [45]. A transition from rolling to arrest involves a shift in
132 integrins from a low- to high-affinity state which allows it to bind intracellular
adhesion molecule-1 (ICAM-1) on endothelial cells (Figure 3) [46]. Following the
arresting step, the leukocyte function associated antigen-1 (LFA-1, also known
as aL132 or CD11a/CD18) [47, 48] plays a critical role for the neutrophil migration
into injured tissue [49]. ICAM-1 can adhere with ringlike cluster of LFA-1 cluster
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during neutrophil transmigration [44]. Therefore, the neutrophil transmigration
across inflamed endothelium is controlled through LFA-1 interactions with ICAM1 [49, 50]. In addition to these molecules, Table 1 shows some other molecules
that play an important role for neutrophil and or IL-17 mediated tissue
destruction.
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Gene

Function

Ref

Ly6G

Defines neutrophils

[51]

ICAM-1

Plays a critical role in the neutrophil recruitment

[48,49]

LFA-1
(CD11a/ldgal)

Plays a critical role in the neutrophil recruitment

[48,49]

Del-1

Inhibits LFA-1-ICAM-1 interactions and limits neutrophil migration to sites
of infection/inflammation

[52]

CD62E

Increases LFA-1 affinity to ICAM-1

[53]

KC (CXCL 1)

Involved in neutrophil chemotaxis

[54,55]

CCL2

Chemokine produced by neutrophils; induces Th17 migration to sites of
inflammation

[56,
58]

CCL20

Chemokine produced by neutrophils; induces Th17 migration to sites of
inflammation

[58-61]

CCR2

Chemokine receptor (responds to CCL2); mediates Th17 recruitment

[57,
62]

CCR6

Chemokine receptor (responds to CCL20); mediates Th17 recruitment

[57,
58,
61,63]

RORyt

Transcription factor; required for Th17 cell differentiation; defines Th17
cells

[64]

IL-6

Promotes Th17 cell differentiation

[65]

TGF-j3

Promotes Th17 cell differentiation

[65]

IL-21

Produced by Th17; induces and amplifies Th17 in cooperation with TGF-j3

[66]

IL-22

Produced by Th17 cells in response to IL-23

[67]

IL-23

Stabilizes the commitment of developing Th17 cells to the Th17 lineage

[65,68]

IL-17A

Control of extracellular pathogens, induction of matrix destruction

[69,70]

TNF-a

Major effector of periodontal bone loss

[71]

IL-1j3

Major effector of periodontal bone loss

[71]

57],[

58,

Table 1. Some other important molecules that play important role in neutrophil
and IL-17 mediated tissue destruction.
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Since circulating neutrophils readily migrate to sites of extravascular
infection or inflammation to eliminate or control pathogenic insults, the
extravasation of neutrophils is critically dependent on a series of well-coordinated
adhesive events, as we discussed above, including the interactions of integrins of
the 132 or 131 family with endothelial countereceptors of the Ig superfamily [40,
43]. In contrast to multiple factors promoting leukocyte extravasation, little
is known about inhibitors of the leukocyte adhesion cascade. In this context, a
52-kDa glycoprotein, known as developmental endothelial locus-1 (Del-1), was
recently identified as a novel negative regulator of neutrophil extravasation acting
by antagonizing the interaction between ICAM-1 and LFA-1 (Figure 4) [52]. It
also has been shown that Del-1 induced engulfment of apoptotic cells [72].
Pentraxin 3 (PTX3) is another recently identified inhibitor of neutrophil
extravasation, which acts by suppressing selectin-dependent rolling [73].

In

contrast to PTX3, however, Del-1 is produced by the tissue rather than the
inflammatory cell itself [52, 73]. Specifically, Del-1 is secreted by endothelial cells
and may associate with the endothelial cell surface and the extracellular matrix
[43, 62]. This observation predicts that Del-1 could play a critical role in
regulating the local chronic inflammatory response in tissues expressing it;
however this hypothesis has not been addressed so far.
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Endothelial cell

Neutrophil

Figure 4. The interaction between Del-1 and LFA-1. Del-1 inhibits the
interaction between ICAM-1 and LFA-1 by binding CD11 a.
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We reasoned that Oel-1 may provide a mechanism whereby a tissue itself
may control or prevent persistent inflammation associated with chronic
recruitment of neutrophils. As we discussed above, periodontitis is a chronic
inflammatory disease and neutrophils modulate its progression [15]. Therefore,
periodontitis represents an attractive model to determine the role of Oel-1 in
neutrophil-mediated chronic inflammation with impact on systemic diseases. Old
age and age-associated inflammation are factors that contribute to increased
prevalence and severity of periodontitis in humans and mice [74, 75]. Our
overall hypothesis is that age-associated reductions in Oel-1 expression
leads to excessive recruitment of neutrophils and increased IL-17A
production in periodontal tissues, resulting in enhanced periodontal
inflammation and periodontal bone loss. (Figure 5). This hypothesis
constitutes a novel mechanism for the increased periodontal tissue destruction
seen in the elderly.
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Significance:

Our proposed experiments are expected to reveal novel

mechanisms of periodontal pathogenesis and pave the way for Del-1-based
therapeutic intervention in periodontitis. On the basis of our hypothesis that Del1 expression decreases with aging, Del-1-based therapy could be extremely
beneficial to elderly patients who run a higher risk for periodontitis [5]. Del-1based control of periodontal disease can also decrease the risk for systemic
inflammatory

diseases,

like

atherosclerotic

heart

disease,

which

epidemiologically and mechanistically linked to periodontitis [37, 76, 77].
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2. MATERIALS AND METHODS

Mice. All mice used were on C57BLl6 background. IL-17RA'- and LFA-r'mice were generously provided, respectively, by Amgen (Seattle, WA)[78] and
Dr. C.M. Ballantyne (Baylor College of Medicine) [79]. The generation of Oel-r'and Oel-r'--LFA-r'- mice was previously described [52]. In this study, the Oel-r'and IL-17RA'- mice were crossed to generate double knock-outs (Oel-r'--IL-

17RA'-). Old C57BLl6 mice (18 months of age) were obtained from the National
Institute of Aging. In aging experiments to investigate the effect of Del-1
deficiency, knockout mice and wild-type littermate controls were reared in parallel
under specific-pathogen-free conditions in individually ventilated cages in the
Barrier Animal Facility of the University of Louisville. All animal procedures
described in this study were approved by the Institutional Animal Care and Use
Committee, in compliance with established federal and state policies.
Determination of periodontal bone loss. Periodontal bone levels were
assessed in defleshed maxillae under a dissecting microscope (x40) fitted with a
video image marker measurement system (VIA-170K; Boeckeler Instruments)
standardized for measurements in millimeters. Specifically, the distance from the
cementoenamel junction (CEJ) to the alveolar bone crest (ABC) was measured
on 14 predetermined points on the buccal surfaces of the maxillary molars [80,
81]. To calculate relative bone loss (e.g., Oel-r'- mice vs. wild-type controls, or
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old mice vs. young controls}, the 14-site total CEJ-ABC distance for each mouse
was subtracted from the mean CEJ-ABC distance of control mice. The results
were expressed in mm and negative values indicated bone loss relative to
controls [80, 81]. In certain experiments, bone loss was measured in mice which
were administered antibiotics in their drinking water (sulfamethoxazole and
trimethoprim at a final concentration of 800 j..Ig/ml and 400 j..Ig/ml, respectively).
Oral bacterial sampling. To assess the oral microbial burden, the murine

oral cavity was sampled for 15 seconds using sterile paperpoints held against the
gumlines [81]. Serial dilutions of the paperpoint extracts were plated onto blood
agar plates for anaerobic growth and CFU determination.
Quantitative real-time peR.

Gingival tissue was excised from around

the maxillary molars. Total RNA was extracted by using the PerfectPure RNA cell
kit (5 Prime, Fisher) and quantified by spectrometry at 260 and 280 nm. The
RNA was reverse-transcribed using the High-Capacity cDNA Archive kit (Applied
Biosystems) and quantitative real-time PCR with cDNA was performed using the
ABI 7500 Fast System, according to the manufacturer's protocol (Applied
Biosystems).

TaqMan probes, sense primers, and antisense primers for

expression of genes examined in this study (Figures 13 and Table 2), or a housekeeping gene (GAPDH), were purchased from Applied Biosystems.
Immunohistochemistry. Upper jaws (maxillae) with intact surrounding

tissue were fixed in 4% paraformaldehyde, decalcified in Immunocal Solution
(Decal Chemical Corp.) for 15 days, and embedded in OCT compound. Serial
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mesio-distal sections (7- to 8-lJm thick) parallel to the long axis of the teeth
(sagittal) were stained with antibodies to human/mouse Del-1 (Proteintech),
mouse Ly6G, a specific neutrophil marker [51] (FITC-conjugate; lifeSpan
BioSciences), human/mouse IL-17A (Santa Cruz Biotech), and human/mouse
TNFa (Abcam). The antibodies to Del-1, IL-17A, and TNFa were rabbit IgG and
staining involved the use of a secondary reagent (Texas red-goat anti-rabbit IgG;
Molecular Probes). The specificity of staining was confirmed by using FITCconjugated isotype control (rat IgG2b) or normal rabbit IgG followed by Texas
red-conjugated goat anti-Rabbit IgG. Images were captured using a laserscanning confocal microscope (Olympus FV1000). Fluorescence intensity was
quantified using the Image J software (NIH; http://rsb.info.nih.gov/ij).
Human samples.

Under IRB approval, samples were collected from

patients undergoing periodontal surgery at the graduate periodontics clinic.
Diseased tissues were usually collected around involved tooth. Healthy tissues
were usually collected from the distal of last molar teeth in maxilla. Diseased
sites were determined if attachment loss was more than 5 mm and/or bleeding
on probing. Excised tissues, nature of periodontal surgery, kept on 10% of
formalin for future staining of Del-1 and/or IL-17A. Gingival tissue samples were
incubated with 10% paraformaldehyde at 4°C and washed with 5%, 10%, and
15% glycerol for 15 minutes. The tissues were immersed in 30% sucrose for 30
min and embedded in a medium for frozen tissues (Tissue-Tek) for cryostat
sectioning (10 IJm). Samples were blocked with 10% BSA (Millipore) at room
temperature for 1 hour, incubated with anti-mouse/human Del-1
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(1/100,

Proteintech) or IL-17A (1/100 Santa Cruz) overnight at 4°C. Following washing
three times with cold PBS, samples were stained with Texas red conjugated antirabbit IgG (1/1000, Invitrogen) or FITC-conjugated donkey anti-goat IgG (1/200,
Santa Cruz) for 1 hour at room temperature. The sections were mounted (Vector)
after washing three times with cold PBS. Subsequently, pictures of the stained
tissue sections were captured using a Confocal microscope (Olympus, V500).

Intervention

experiments.

Ten

18-month-old

C5BLl6

mice

were

microinjected in the gingiva with soluble recombinant mouse Oel-1 (kindly
provided by Valentis, Inc.) [52] and another ten mice with BSA control.
Specifically, Oel-1 or BSA (1 I-Ig in 1-1-11 volume) were microinjected through a
28.5-gauge MicroFine needle (BO) into the palatal gingiva between the first and
the second molar teeth, on both sides of the maxilla (Figure 6). Half of the Oel-1or BSA-treated mice were additionally orally inoculated with P. gingiva lis ATCC
33277 (10 9 CFU) in 2% carboxymethylcellulose vehicle and the other half were
orally given vehicle only. To determine whether IL-17 regulates Oel-1 expression
in old mice, a neutralizing anti-IL~17 mAb (clone M210, rat IgG2a, kindly provided
by Amgen) or 11-1g of azide-free rat IgG2a (Biolegend), served as a control, were
microinjected into interdental papilla between 1sl and 2nd molar from palatal side.
All mice were sacrificed 12 h later. Maxillae were harvested and one side was
stored in 4% paraformaldehyde (for immunohistochemistry; see above) while the
other side was used to dissect interdental gingiva (between first and second
molar teeth), which were placed into RNA-later solution (Ambion) for quantitative
real-time PCR (see above).
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Numbers
indicate Days
P.g INFECTION

11/

Figure 6. Del-1 intervention assay. Oel-1-Fc (1

1-11

of a 10l-lg/ml solution) was

administered through microinjection (using a 2B .5-gauge MicroFine needle; BO)
into the palatal gingivae between the first and the second molar, one hour prior to
each infection. Control mice were microinjected a similar concentration of bovine
serum albumin (BSA) . This study, therefore , involved four groups of aged mice
(5 animals per group): Sham-infected treated with BSA, Sham-infected treated
with Oel-1-Fc, P. gingiva/is-infected treated with BSA, P. gingiva/is-infected
treated with Oel-1-Fc. Experimental and control aged mice (5 per group) were
microinjected with Oel-1-Fc and BSA, respectively , a total of three times every
other day. Following each administration of Oel-1-Fc or BSA, the mice were also
orally infected with 109 CFU P. gingiva/is 33277 in 2% carboxymethylcellulose.
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To determine if IL-17 regulates Del-1 expression in old mice, a neutralizing antiIL-17 mAb was microinjected using the method as described above. The mice
were euthanized 12h after the last infection.

Statistical analysis. Data were evaluated by analysis of variance and the

Dunnett multiple-comparison test using the InStat program (GraphPad Software,
San Diego, CA). Where appropriate (comparison of two groups only), two-tailed

t

tests were performed. p < 0.05 was considered to be significant. All experiments
were performed at least twice for verification.
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3. RESULTS

Aged mice show decreased Del-1 expression which correlates with
increased bone loss.
Old age is associated with increased susceptibility to chronic inflammatory
diseases [2, 82-84] several of which, including periodontitis, involve neutrophilmediated tissue injury [12, 16, 42, 85-87]. However, none of these diseases have
been linked to age-associated alterations in Del-1 expression, which could be
responsible for dysregulated chronic recruitment of neutrophils to affected
tissues. Aging mice, like aging humans, can naturally develop periodontal bone
loss [74, 84]. We therefore examined whether age-related mouse periodontitis is
associated with changes in Del-1 expression. Given that Del-1 is expressed in
select tissues (e.g., brain and lungs but not liver or spleen) [43], we first
examined and showed that Del-1 is expressed in the gingival tissue of the
periodontium at the mRNA and protein level (Figure 7). Similar to previous
findings in BALB/c mice [74], C57BLl6 mice (used throughout this study)
developed periodontal bone loss in advanced age (Figure 8b). Intriguingly,
gingival tissue harvested from 18-month-old mice displayed about 4-fold lower
expression of Del-1 mRNA than gingiva from young mice (8- to 10-week old)
(Figure 9b) and a pronounced difference was also noted at the protein level
(Figure 9a, upper row).

Interestingly, the reduced expression of Del-1 in the
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gingiva of old mice was associated with higher neutrophil infiltration relative to
young mice (Figure ga, lower row). Moreover, we found that periodontal tissue
harvested from old mice (>18 months) exhibited about 3-fold more expression of
IL-17 than periodontium from young mice (Figure 10).
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Figure 7. Del-1 is expressed in the mouse gingiva. (a) Brains , livers, and
gingiva were harvested from 8-week-old C57BLl6 mice and processed for
quantitative real-time PCR to determine Oel-1 mRNA levels (normalized against
GAPOH mRNA; data are means ± SO , n

= 3 mice per group) . (b)

Brains , livers,

and gingiva were stained for Oel-1 protein . Brain and liver served as positive and
negative controls , respectively, for gingiva .
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•
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w.~

~ 025

•

Young

•

Young

Old

in old mice correlates with

periodontal bone loss. (a) Increased bone loss in old C57BLl6 mice (18 months
of age) compared to young controls (8-10 weeks), calculated based on measured
distances between the cementoenamel junction (CEJ) and the alveolar bone
crest (ABC) . (b) Gingiva were dissected from the same mice and qPCR was used
to determine Del-1 mRNA expression levels (normalized against GAPDH mRNA
and expressed as fold change of old relative to young mice, the average value of
which was taken as 1. Data are means ± SO ; n=5 mice per group) . **p<0.01
compared to young controls.
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Figure 9. Reduced expression of Del-1 in old mice correlates with increased
number of neutrophils. (a) Sagittal sections of interdental gingiva of young
(C57BLl6 , 20 weeks) and old mice (C57BLl6, 18 months of age) were stained for
Oel-1 protein (upper left) and the neutrophil-specific marker Ly6G (lower left) ;
shown are representative overlays of differential interference contrast and
fluorescent confocal images (scale bar, 50lJm ; T, tooth ; G, gingiva ; S, sulcus) . (b)
The fluorescence intensities of shown image (a) and of additional representative
images from independent mice were quantified using ImageJ analysis (data are
means ± SO ; n=5 mice per group) .
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Figure 10. IL-17 expression is increased in old mice. (a) Sagittal sections of
interdental gingiva of young and old mice were stained for IL-17. (b)
Fluorescence intensity was quantified using ImageJ analysis. Data are means ±
SO (n=4 ; mice per group) . This experiment was repeated three times.
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Figure 8a shows the individual values for the measured distances between the
cementoenamel junction (CEJ) and the alveolar bone crest (ABC), which were
used to calculate the relative bone loss in old mice (Figure 8b). Linear-regression
analysis of the CEJ-ABC values versus Del-1 expression (data from figures 1a
and 1b, respectively) revealed a significant inverse association between Del-1
expression and periodontal bone loss in old mice (Figure 11 a) (~ = 0.6254, P =
0.0065).

This association was also significant, but not as strong, within the

young group (~

=0.4641, P =0.0301; Figure 11 b). Thus, an inverse relationship

between Del-1 expression and bone loss exists not only between young and old
mice (Figure 8b and c), but also within the individual age groups. These data
suggest that aging is associated with Del-1 deficiency in the periodontium which
may contribute to dysregulated neutrophil recruitment and induction of bone loss.
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Figure 11. Reduced expression of Del-1

in old mice correlates with

periodontal bone loss. Linear-regression analysis of the CEJ-ABC distance
values versus Del-1 expression in old (a) and young (b) mice using the data from
figure 9a and b. (n=5 mice per group).
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Del-1"'- mice exhibit enhanced inflammation and bone loss
To determine a direct role for Del-1 in preventing local inflammatory
pathology, we investigated the periodontal phenotype of Del-1-1- mice. Sixteenweek-old Oel-1-1- mice of either gender exhibited significant periodontal bone loss
relative to their respective age-matched wild-type controls (Figure 12a). Female
and male Oel-r'- mice had similar susceptibility to periodontitis, and further
studies utilized exclusively females. To exclude the possibility that the observed
bone loss in 16-week-old Oel-r'- mice relative to age-matched wild-type controls
(Figure 12a) was due to innately different periodontal bone levels, we examined

Oel-r'- and wild-type mice at different ages. At the age of 5 weeks, no difference
in the bone levels between Oel-r'- and wild-type mice was observed, whereas
progressive differences were seen with advancing age (Figure 12b). Therefore,
the bone loss exhibited by Oel-r'- mice is an acquired rather than an innate trait.
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Figure 12. Del-1 deficiency is associated with inflammatory bone loss. (a)

Sixteen-week-old C57BLl6 wild-type (WT) or Oel-r'- mice, of either gender, were
assessed for periodontal bone levels. (b) Periodontal bone levels in female mice
of the indicated ages. Negative values indicate bone loss relative to WT controls
serving as the baseline . Data are means ± SO (a & b , n=4 ; mice per group) .
*p<O .05 ; **p<O .01 compared to correspond ing control.
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Analysis

of

the

periodontal

inflammatory

response

by

real-time

quantitative PCR (qPCR) showed significant differences between 16-week-old
Oel-1-1- and age-matched wild-type mice, characterized by >6-fold elevated

expression of IL-17A upon Oel-1 deficiency (Figure 13); this difference was
confirmed at the protein level by immunohistochemistry (Figure 14a). A less
pronounced but statistically significant increase was observed in the transcript
levels of other inflammatory mediators, such as proinflammatory and boneresorptive

molecules (TNF,

IL-6,

RANKL),

chemokines

(CCL2,

CCL20),

chemokine receptors (CCR2, CCR6), receptors that amplify inflammation (C3aR,
C5aR, TREM-1), and costimulatory molecules (C040, COB6) (Figure 13).
Importantly, the increased inflammation and bone loss in Oel-rl- mice was
associated with increased infiltration of neutrophils in the gingiva (Figure 14b-c),
consistent with lack of Oel-1-mediated regulation of neutrophil trafficking.
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Figure 13. Del-1 deficiency is associated with inflammatory response in the
periodontium .

Sixteen-week-old C57BLl6 wild-type (WT) or De/-rl- mice , of

either gender, were assessed for inflammatory response . Gingiva were dissected
from 16-week-old WT or De/-rl- mice and gingival mRNA levels of the indicated
molecules were determined by qPCR (normalized against GAPDH mRNA and
expressed as fold change in De/-1 -1- transcript levels relative to WT , the average
value of which was taken as 1. Data are means ± SO (n=4 ; mice per group) .
*p<O .05 ; **p<O .01 compared to corresponding control.
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B

Figure 14. Increased recruitment of neutrophils and expression of IL-17 in
the gingiva of Del-1-1- mice. (a)

Sagittal sections of maxillary teeth from 16-

week-old WT or Oe/- r '- mice were stained for IL-17A (upper left) or the
neutrophil marker Ly6G (upper right) . Shown are representative fluorescent
confocal images (left) and corresponding differential interference contrast images
(right) . T, tooth ; G, gingiva ; S, sulcus . (b) The fluorescence intensities of images
shown above (corresponding to IL-17 expression and neutrophil recruitment in
the gingiva , respectively)

and

of additional

representative

images from

independent 16-week-old wild-type (WT) and Oe/-r'- mice were quantified using
ImageJ analysis. Data are means ± SO (n = 5 mice per group) . **p < 0.01
compared to young control.
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Although it is the host inflammatory response that primarily can inflict
damage upon the periodontal tissue, anaerobic oral bacteria are involved in the
initiation and progression of periodontitis [4, 16, 88]. In this regard, Oel-r'- and
wild-type mice initially harbored comparable levels of oral anaerobic bacteria;
however, from the age of 8 weeks onward, Oel-r'- mice exhibited a Significantly
higher bacterial burden relative to age-matched wild-type controls (Figure 15a).
The development of periodontal bone loss in Oel- r

l

-

mice was prevented by oral

antibiotic treatment (Figure 15b), confirming the role of bacteria in this bone loss
model, as in human periodontitis [88]. In summary, the periodontal tissue of Oel-

rl -

mice displays unregulated neutrophil infiltration, elevated bacterial burden,

and inflammatory bone loss, indicating that Del-1 deficiency compromises host
homeostasis.
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Figure 15. Del-1 deficiency is associated with elevated numbers of bacteria
in the periodontium . (a) Wild type (WT) and Oe/-r'- mice at the indicated ages
were assessed for oral anaerobic bacteria (CFU shown for each mouse with
horizontal lines denoting mean values) . (b) Oe/-r '- mice were given antibiotics in
the drinking water upon weaning (plain water served as control) and at 14 weeks
were assessed for bone loss relative to 5-week-old Oe/-r '- mice.

Data are

means±SD (a & b, n=5 mice per group) . *p<O .05 ; **p<O .01 compared to
corresponding control.
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Inflammatory bone loss in Del-1 deficiency requires LFA-1 function and IL17R signaling
Since Del-1 acts as an antagonist of LFA-1 integrin-dependent neutrophil
adhesion [52], we next addressed whether the bone loss seen in Oel-r'- mice
could be attributed to increased LFA-1-mediated inflammatory cell recruitment.
To this end, we examined the phenotype of mice with combined Del-1 and LFA-1
deficiency (Oel-r'--LFA-r'l We found that the periodontal bone loss associated
with Del-1 deficiency was drastically (>75%) reversed in Oel-r'--LFA-r'- mice
(Figure 16a), which additionally displayed reduced neutrophil infiltration in the
gingiva as compared to Oel-r'- mice (Figure 16b and Figure 17b). Therefore, the
protective role of Del-1 against periodontitis may be mediated through regulation
of LFA-1-dependent neutrophil trafficking.
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Figure 16. Increased bone loss and neutrophil number in Del-1-1- is reversed
in mice with dual Del-lILFA-1 deficiency. (a) Twenty-week-old C57BLl6 wildtype (WT) mice or mice genetically deficient in the indicated molecules were
assessed for periodontal bone levels. (b) Sagittal sections of interdental gingiva
from the same mice were stained for the neutrophil marker Ly6G ; shown are
representative overlays of differential interference contrast and fluorescent
confocal images. Data are means ± SO (a & b , n=5 ; mice per group). **p < 0.01
compared to WT control. Scale bars represent 50j.Jm.
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Figure 17. Del-1 deficiency-associated inflammatory response is reversed
in mice with dual Del-1/LFA-1 deficiency. (a) Twenty-week-old Del-1 -1- or Del-

1-1- / LFA-1 -1- mice were sacrificed to detect the indicated molecules including IL17 and Ly6G . Sections of interdental gingiva from the indicated mice were
stained for IL-17 (left) and Ly6G (middle) with colocalization shown in merged
images (right) ; the bottom row includes magnified views of the demarcated areas
just above. (b) The fluorescence intensities of the images shown here and of
additional representative images from independent mice were quantified using
ImageJ analysis . Data are means ± SO (a and b, n=5 ; mice per group) . **p <
0.01 compared to indicated control. Scale bars represent 50lJm .
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Moreover, in comparison to Oe/-r'- mice, the Oe/-r'--LFA-r'- mice
displayed decreased gingival levels of IL-17 (Figure 17a and b) due to, at least in
part, reduced infiltration of neutrophils which expressed IL-17. In this regard, we
observed colocalization of IL-17 and Ly6G (specific neutrophil marker) in gingival
tissues of both Oe/-r'- and Oe/-r'--LFA-r'-mice by immunohistochemistry
(Figure 17a). This observation is consistent with the notion that much of the IL-17
released at sites of inflammation derives from innate immune cells, including
neutrophils [89].
As Oel-r'- mice had high IL-17 levels relative to both WT and Oel-r'--LFA-

r'-

mice, we then sought to address the precise role of IL-17 in the observed

bone loss due to Del-1-deficiency. Predicting the role of IL-17 in diseasewhether protective or destructive- is often uncertain, since IL-17 can mediate
both antimicrobial host defenses and immunopathology [4, 22]. To conclusively
address the role of IL-17, we generated mice with combined Del-1 and IL-17
receptor (IL-17R) deficiency. Oel- r'--IL-17F?'- mice were completely protected
against bone loss and were essentially indistinguishable from wild-type or IL-17R,- mice (Figure 18a and Figure 19), suggesting that IL-17R signaling is required
for induction of periodontal bone loss associated with Del-1 deficiency.

The

same experiment confirmed that Oel-r'--LFA-r'- mice are protected against
periodontitis, whereas LFA-rl- mice developed significant bone loss relative to
wild-type mice (Figure 18a), suggesting that normal neutrophil trafficking (as
opposed to excessive in the absence of Del-1

regulation) may mediate

protection. All six genotypes used in these experiments had comparable bone
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levels in early age (5 weeks) (Figure 20), ruling out an innate etiology for the
bone loss differences seen amongst the distinct mutant mice (Figure 18a). In
addition, the increased load of oral anaerobic bacteria due to Del-1 deficiency
(Figure 15a) was significantly reversed in both Oel-rl--LFA-rl- and Oel-rl--IL-

17R-1- mice (Figure 18b).
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Figure 18. Del-1 deficiency-associated inflammatory bone loss is reversed
in mice with dual Del-1/LFA-1 or Del-1I1L-17R deficiencies. (a) Twenty-weekold C57BLl6 wild-type (WT) mice or mice genetically deficient were assessed for
periodontal bone levels. (b) CFU are shown for each mouse with horizontal lines
denoting mean values.

In a, negative values indicate bone loss relative to

baseline bone levels of WT mice. Data are means ± SD (a, n=5 ; b, n=9-11 mice
per group). **p < 0.01 compared to WT or indicated control.
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Figure 19. Del-1 deficiency-associated bone loss is reversed in mice with
dual Del-1/LFA-1 or Del-111L-17R deficiencies . Representative images of
maxillae (upper jaws) from the bone loss measurement experiment shown
above. The

bone gap [distance from the

alveolar bone crest to the

cementoenamel junction (a)] is greatest in the Oel-rl- mice, whereas mice with
combined deficiencies (Oel-r l--LFA-1-1- or Oel-rl--IL-17R"1-) have bone levels
comparable to those of wild-type (WT) mice (b) . See above for quantitative
results.
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Figure 20. Bone loss in different genotype comparable periodontal bone
levels in early-age mice regardless of genotype. Five-week-old C57BLl6 wildtype (WT) mice or mice genetically deficient in the indicated molecules were
assessed for periodontal bone levels . The mm distance from the cementoenamel
junction (CEJ) to the alveolar bone crest (ABC) was measured at 14
predetermined sites in defleshed maxillae and was totaled for each mouse. (a)
Data are shown for each mouse and horizontal lines indicate the mean value . (b)
The data from panel 'a' were transformed to directly indicate bone level
differences relative to the wild-type mice which served as the baseline . No
significant differences were found among the groups (n
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= 6 to 8 mice per group) .

These findings indicate that Del-1 deficiency causes periodontal bone loss
that is dependent on LFA-1-dependent neutrophil recruitment and IL-17R
signaling. Moreover, conditions that restore tissue homeostasis in terms of
periodontal

bone

maintenance

(i.e.,

dual

Del-1/LFA-1

or

Del-1/IL-17R

deficiencies) also reverse the numbers of oral bacteria to near normal levels.

IL-17 regulates Del-1 expression as a function of age

As IL-17 can orchestrate the production, chemotactic recruitment, and
activation of neutrophils during inflammation [26, 27], we next examined whether
IL-17 can additionally regulate Del-1 expression. To this end, we found that IL-

17R"'- mice exhibited increased gingival Del-1 expression relative to Wild-type
controls (Figure 21, A-C). Consistent with the possibility that IL-17 downregulates
Del-1 expression, local microinjection 1f.!g of a neutralizing monoclonal antibody
to IL-17 (clone M170) into the gingiva of old mice resulted in significant
upregulation of Del-1 expression, whereas an isotype control had no effect
(Figure 21 D). Furthermore, the gingival expression of IL-17 was enhanced in old
age (Figure 21 E), in stark contrast to the decreased Del-1 expression in old mice
(Figure B8). Moreover, linear-regression analysis of Del-1 expression versus IL17 expression (data from figures 18 and 4D, respectively, involving same set of
1B-month-old mice) revealed a significant inverse association between IL-17 and
Del-1 (r2 = 0.6274, P = 0.0063; (Figure 21 F). Taken together, the Figure 4 data
demonstrate that Del-1 expression in the periodontal tissue is regulated by IL-17
as a function of age.
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6

Figure 21. Del-1 expression is downregulated by IL-17 in old SPF mice. (a)

Gingival Oel-1 mRNA expression levels in wild-type (WT) and IL-17R-/- mice
determined by qPCR (normalized against GAPOH mRNA and expressed as fold
change relative to WT, the average value of which was taken as 1). Results are
shown for each individual mouse. (b) Sagittal sections of interdental gingiva of
WT and IL-17R-/- mice were stained for Oel-1 protein; shown are representative

fluorescent confocal images (upper row) and their overlays with corresponding
differential interference contrast images overlays (lower row). Scale bar, 501Jm;
T, tooth; G, gingiva; S, sulcus. (c) The fluorescence intensities of the images
shown here in B and of additional representative images from independent mice
were quantified using ImageJ analysis (data are means ± SO; n=5 mice per
group) (d) Anti-IL-17 mAb (M210) and IgG2a isotype control were microinjected
into the palatal gingiva and qPCR was used to determine gingival Oel-1 mRNA
expression. (e) GingivallL-17 mRNA expression was determined in young (8-10week old) and old (18 months of age) mice using qPCR. (f) Linear-regression
analysis of the Oel-1 expression versus IL-17 expression in old mice. **p < 0.01
compared to untreated, WT, or young controls.
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Local administration of soluble Del-1 reverses periodontal inflammation in
old mice.

We next determined whether recombinantly expressed soluble Del-1 could
be exploited therapeutically to reverse periodontal inflammation in old mice,
which express relatively low levels of Del-1 (Figure 8 and Figure 9). Indeed, local
gingival microinjection of soluble Del-1 resulted in reduced neutrophil infiltration
(Figure 22a) and diminished expression of IL-17 (Figure 22b) and TNFa (Figure
22c) in the periodontium compared to similar treatment with BSA control (Figure
22d). Notably, Del-1 treatment of old mice suppressed both constitutive (naturally
occurring) inflammation (Figure 22a, b, c; upper rows) as well as inflammation
induced by exogenous oral inoculation with the human pathogen Porphyromonas
gingivalis (Figure 22a, b, c; lower rows). The ability of soluble Del-1 to reduce
expression of IL-17 and TNFa protein was confirmed at the mRNA level by qPCR
which additionally revealed reduced transcript levels of a number of other
inflammatory mediators (such as proinflammatory cytokines, chemokines,
chemokine receptors,

pattern-recognition and complement receptors, and

costimulatory molecules;

(Table 2). These data provide proof-of-concept

evidence that Del-1 has therapeutic potential for the treatment of periodontal
inflammation, and perhaps other neutrophil-mediated inflammatory diseases [12,
42,85,86].
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Figure 22. Del-1 treatment reverses periodontal inflammation in old mice.
Eighteen-month old C57BLl6 mice were microinjected in the gingiva with BSA
(control) or Oel-1 , as indicated . In addition , the mice were orally administered P.
gingiva/is in 2% carboxy-methylcellulose vehicle (a, b, c; lower rows) or vehicle

control (a, b, c; upper rows) and were sacrificed 12h later. Sagittal sections of
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interdental gingiva were stained for the neutrophil marker Ly6G (a), IL-17A (b), or
TNFa (c). Shown are typical fluorescent confocal images (left) and their overlays
with corresponding differential interference contrast images (right). (d). The
fluorescence

intensities

of the

images

shown

here

and

of additional

representative images from independent mice were quantified using ImageJ
analysis; data were expressed as % intensity of the Del-1-treated groups relative
to the BSA-treated controls, the value of which was set to 100% ('Induced
inflammation' refers to the groups inoculated with P. gingiva/is). Data are means

± SO (n=5 mice per group). **p < 0.01 compared to BSA-treated controls.
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Molecule

Fold change vs.
Del-1-untreated controls
Pg
CMC

IL-17
TNF
IL-6
IL-1
RANKL
G-CSF
CCL2
CCL3
CCL20
CXCL 10
CCR2
CCR6
CXCR4
C3aR
C5aR
TREM-1

0.19
0.50
0.25
0.50
0.49
0.12
0.48
1.02
0.24
0.25
0.26
0.25
0.50
0.49
0.50
0.49

0.25
0.51
0.24
0.25
0.25
0.25
0.49
0.51
0.49
0.26
0.12
0.13
0.24
0.49
0.25
0.24

TLR1
TLR2
TLR4
TLR5
TLR6
TLR9
C040

0.24
0.26
0.25
0.51
0.27
0.25
0.24

0.24
0.25
0.12
0.51
0.26
0.51

C080
C086

0.25
0.50
53

0.25
0.25
0.49

Table 2. Reduced mRNA levels of inflammatory mediators in the gingiva of
aged mice after local administration of soluble Del-1. Eighteen-month-old
C57BLl6 mice were microinjected with BSA (control) or Del-1 in the palatal
gingiva between the first and the second molar teeth. The mice were then orally
inoculated with 109 CFU Porphyromonas gingiva lis in 2% carboxymethylcellulose
(CMC) or CMC only, and were sacrificed 12h later. The interdental gingiva (i.e.,
between first and second molar teeth) were dissected and processed for
quantitative real-time PCR (qPCR) to determine gingival mRNA levels of the
indicated molecules (normalized against GAPDH mRNA levels and expressed as
fold change of Del-1-treated relative to corresponding BSA-treated controls). To
ensure enough tissue material, dissected interdental gingiva from 5 mice per
group were pooled before use in the qPCR. Consistent results were obtained
from an identical independent experiment.
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Del-1 expression is reduced in periodontitis patients.

According to BLAST analysis, human and mouse Del-1 share 96% aminoacid sequence identity, which readily explains why human Del-1 is functional in
mice [90]. The purpose of these studies was to determine if the low Del-1 and
high IL-17 expression seen in mouse periodontitis was relevant in human
periodontitis. Tissues, which were harvested from healthy and diseased areas in
the same subject, were stained for Del-1

expression. According to our

preliminary data, Del-1 expression was dramatically reduced in diseased area as
compared to healthy areas (Figure 22A). We next determined if IL-17 expression
increased in diseased gingiva. We found, in contrast to reduced Del-1
expression, that IL-17 expression was markedly increased in diseased areas
(Figure 22B). Those results were consistent what we have found in old or Del-1
deficient mice (see above).
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Del-l

Il-17

A (Healthy)

B (Disease)

Figure 23. Expression of IL-17 and Del-1 in human gingival. (a)

Sagittal

sections of human gingiva from healthy (a) or diseased (b) sites were stained for
Del-1 (left) or IL-17A (right). This is a preliminary data and utilized from two
patients.
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4. DISCUSSION

We showed here for the first time that Del-1 (a) serves a mechanism by
which a tissue can control the local inflammatory response to prevent
immunopathology and (b) may be a promising novel therapeutic for inflammatory
diseases. Specifically, Del-1 is required for homeostatic inhibition of inflammatory
periodontal bone loss involving LFA-1-dependent neutrophil recruitment and IL17R signaling.
Importantly, Oel-r'- mice developed periodontitis naturally in a chronic
setting of dysregulated neutrophil recruitment without requiring experimental
intervention (e.g., superinfection with a human periodontal pathogen or injection
of bone loss-inducing agents such as lipopolysaccharide) as is often required in
animal periodontitis models [91]. A phenotype comparable to that of Oel-r'- mice
was mirrored in wild type old mice, in which inflammatory bone loss increased
linearly with reduced expression of Del-1.
In turn, IL-17, which was expressed at higher levels in old age, negatively
regulated Del-1 expression. This finding reveals a novel mechanism whereby IL17 orchestrates neutrophil recruitment. Previously, it was shown that IL-17
promotes granulopoiesis and induces the chemotactic recruitment, activation,
and survival of neutrophils [26-28]. Now we show that IL-17 also suppresses
endogenous inhibitory mechanisms to facilitate the recruitment of neutrophils to

57

sites of infection. This function may be beneficial in the acute defense against
infection, although- as shown here- it can become detrimental under chronic
conditions. Persistent recruitment and infiltration of neutrophils into peripheral
tissues may contribute to the pathogenesis of additional chronic inflammatory
diseases, such as rheumatoid arthritis, inflammatory bowel disease, and chronic
inflammatory lung diseases [12, 13, 42, 92]. Therefore, interventional approaches
aiming to downregulate the recruitment or activation of neutrophils (e.g., Del-1 or
anti-IL-17 biologics) may offer treatment solutions.
The spontaneous disease phenotype of Oel-r/- mice suggests that the
tissue may have greater control over the local host inflammatory response than
the immune system itself. Del-1 acts locally in tissues that express it, such as the
periodontium, by competing with LFA-1- dependent adhesion of neutrophils to
endothelial ICAM-1 [52]. The restricted expression pattern of Del-1 likely confers
its tissue-specific anti-inflammatory activity [43]. This role of Del-1 is in line with
recent findings that growth differentiation factor-15, locally produced in the heart,
protects the infarcted myocardium from excessive neutrophil infiltration by
inhibiting integrin activation [14]. This recent study and our current findings
support an emerging concept that tissues have evolved distinct local homeostatic
mechanisms to control inflammatory cell recruitment and prevent tissue damage.
To our knowledge, the abrogation of periodontitis in Oel-r /--IL-17R-1- mice
represents the first time that IL-17R signaling is causally linked to periodontal
bone loss, consistent with the elevated level of IL-17 in human periodontitis [4,
93, 94]. Our findings are thus consistent with the elevated levels of IL-17 in
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human periodontitis [4, 93-95] and in mouse periodontitis models [74, 96]. IL-17
was also shown to stimulate antimicrobial immunity and thereby to inhibit
pathogen-initiated bone loss in a relatively acute periodontitis model [97];
however, chronic IL-17R signaling can turn an acute inflammatory response into
chronic immunopathology, as seen in rheumatoid arthritis [4, 22]. In this context,
IL-17 can mediate connective tissue destruction and bone resorption efficiently
and independently of IL-1 ~ and TNF-a; the underlying mechanisms are largely
dependent on induction of matrix metalloproteases and RANKL (receptor
activator of nuclear factor-KB ligand) [22, 98]. In this regard, the Oel-rl- mice
exhibited 3-fold higher RANKL expression in the gingiva than wild-type controls,
although

both

groups

had

similar expression

of the

RANKL

inhibitor,

osteoprotegerin (OPG) (Fig. 13).
Furthermore, the recent demonstration that neutrophils express RANKL
underscores their potential to directly engage in inflammatory bone destruction
[99]. Although IL-17 is a signature cytokine of the CD4+ T-helper 17 subset,
much of the IL-17 in inflammatory sites is actually contributed by innate immune
sources [89]. Accordingly, we observed co localization of IL-17 and neutrophils in
the gingiva. Neutrophils are thought to mediate periodontal tissue destruction
through the release of inflammatory cytokines, oxygen radicals, and matrixdegrading metalloproteases [19, 100]. The interplay between neutrophils and IL17 may generate a positive feedback loop of persistent neutrophil-mediated
inflammation, which can be reversed, however, by local administration of Del-1,
as indicated by its ability to inhibit IL-17 expression. This finding and our data that
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the age-associated downregulation of Del-1 was mediated by IL-17 suggest a
reciprocal cross-regulation of the two molecules.
Dysregulated LFA-1-dependent recruitment is apparently the proximal
cause for the increased neutrophil infiltration in the gingiva of Del-1-deficient
mice. However, IL-17, the gingival expression of which was significantly elevated
in genetic and age-associated Del-1 deficiency, could contribute to sustaining
high neutrophil numbers. In this regard, IL-17 promotes granulopoiesis and
orchestrates the recruitment, activation, and survival of neutrophils [26, 27].
Moreover, IL-23, which is a potent inducer of IL-17 production by both adaptive
and innate immune sources [101, 102], was also upregulated (both IL-12/IL23p40 and IL-23p19 subunits were expressed at ==3-fold higher levels in Oe/-rlrelative to wild-type mouse gingiva; Fig. 14a). Therefore, Del-1 deficiency causes
enhanced neutrophil recruitment and IL-17 production, the interplay of which
could generate a positive feedback loop of persistent neutrophil-mediated
inflammation.
Neutrophils are key effectors of periodontal tissue destruction through the
release of inflammatory cytokines, oxygen radicals, and matrix-degrading
metalloproteases [16, 87, 100]. The recent demonstration that neutrophils
express RANKL underscores their potential to directly engage in inflammatory
bone destruction [103, 104]. Although neutrophils play crucial roles in the acute
defense against infection, their persistent recruitment and infiltration into tissues
may contribute to the pathogenesis of additional chronic inflammatory diseases,
such

as

rheumatoid

arthritis,

inflammatory bowel disease,
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and

chronic

inflammatory lung diseases [12, 13, 42, 85, 86]. Therefore, interventional
approaches aiming to downregulate the recruitment or activation of neutrophils
(e.g., Del-1 or anti-IL-17 biologics) may offer treatment solutions.

Since the proximal consequence of Del-1 deficiency is elevated LFA-1dependent neutrophil recruitment, the reason(s) for the increased oral microbial
burden in Oe/-rl- mice is not obvious. It is possible that excessive cellular
recruitment and inflammation creates an environment that impairs the neutrophil
defensive functions, as seen in sepsis [105], leading to uncontrolled bacterial
growth.

Indeed, in sepsis, neutrophils can undergo 'immune paralysis', a

condition

largely dependent on

C5aR signaling

[105].

Interestingly, the

expression of C5aR (and other receptors that amplify inflammation such as C3aR
and TREM-1) was elevated in the absence of Del-1 (Fig. 13). Alternatively (or
additionally), under inflammatory conditions, the gingival inflammatory exudate
becomes a rich source of nutrients, such as hemin-derived iron and degraded
host proteins, which would favor the growth of periodontal bacteria [88, 106]. The
notion that inflammation contributes to bacterial growth is consistent with our
observation that the high oral microbial burden associated with Del-1 deficiency
was restored to near normal levels in Oe/-rl--LFA-rl- and Oe/-rl--IL-17R/- mice,
which had reduced periodontal inflammation relative to Oe/-rl- mice. This positive
reinforcement loop between inflammation and bacterial growth can perpetuate
inflammatory tissue destruction, since increased levels of bacteria can in turn
elicit even higher inflammation and bone loss.
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The majority of the adult population experiences some form of periodontal
disease and an estimated 10-15% develops severe periodontitis, which has
significant economic consequences [107] and is a risk factor for systemic
conditions [37, 76, 108, 109]. Moreover, old age is associated with increased
prevalence and severity of periodontitis and a number of other chronic
inflammatory diseases [2, 82, 84, 110]. The term 'inflamm-aging' was aptly
coined to describe the heightened chronic inflammatory state often associated
with old age in humans [111]. In this regard, the elderly show inappropriately high
periodontal inflammatory responses relative to young individuals following
comparable de novo biofilm formation [84]. A similar condition may apply to old
mice which develop overt periodontitis [74]. From a mechanistic viewpoint, little
is known regarding the impact of aging on innate immunity and inflammatory
diseases [82, 84]. However, the reduced expression of Del-1 could be a major
mechanism linking advanced age to destructive periodontal inflammation.

Our findings support the feasibility of controlling the influx of neutrophils
and ensuing inflammation through Del-1 treatment. Conventional periodontal
treatment is often not sufficient by itself to control destructive inflammation and
many patients develop recurrent disease [112]. Del-1 may thus offer a promising
approach to treat periodontitis and reduce the risk for associated systemic
diseases, whereas the anti-inflammatory properties of Del-1 may also find
application in other inflammatory and autoimmune diseases [12, 42, 85, 86].

62

5. CONCLUSION
We showed that Del-1, a novel inhibitor of integrin-dependent neutrophil
adhesion, regulates local tissue-specific inflammation and controls chronic
inflammatory disease.

Upon aging,

normal mice developed periodontitis

accompanied by diminished Del-1 expression. Consistent with a homeostatic role
for Del-1, Del-1-1- mice developed spontaneous periodontitis featuring excessive
local neutrophil infiltration and IL-17 expression. Disease was reversed in Del-1-1mice with additional deficiencies in the LFA-1 integrin or the IL-17 receptor.
Intriguingly, Del-1 and IL-17 were reciprocally cross-regulated and the diminished
expression of Del-1 in old age was associated with elevated IL-17 expression.
The function of the immune system declines with age. It therefore follows
that the complex cytokine network that orchestrates cell-cell interactions is also
affected by age. Those age-associated changes in cytokine production have
been investigated previously in both humans and rodents [113, 114]. For
example, it has been shown that aging increased inflammation by inducing
production of proinflammatory cytokines and chemokines such as IL-6 and
CCL2, respectively [115]. It is well known that overproduction of IL-6 is
associated with a spectrum of age-related conditions including cardiovascular
disease, osteoporosis, arthritis, type 2 diabetes, certain cancers, and periodontal
disease. Consistently, we have shown that the age-association of certain pro-
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inflammatory cytokines, including IL-1J3, TNF-a, IL-17A and IL-6, increased in the
gingivae [74]. We also, in this study, found that reduction of inflammatory
cytokines and chemokines production increased in Del-1

deficient mice.

Together, it is clear that the host immune system is dysregulated by age.
Homeostasis following periodontal injury is essential for the tissue
regeneration or repair. Dysregulated homeostatis is associated with chronic
inflammatory diseases, including rheumatoid arthritis, psoriasis, inflammatory
bowel disease and

periodontitis

afflicting

millions of people worldwide.

Susceptibility to chronic disease is most likely genetically determined and
immune response play a crucial role for the disease prognosis. Pro- or antiinflammatory cytokines induced locally modulate the course of the response
whereby they can modulate the host response, which is the resistance or
susceptibility to the particular pathogen. For example, it has been shown that IL4, IL-10, IL-13 and TGF-P., are some of key anti-inflammatory cytokines resulting
tissue homeostasis in periodontium [17]. IL-4 contributes to negative immune
regulation by reducing IL-2 receptor [116] or production of TNF-a, IL-1 and IL-6 in
monocytes [117]. IL-10 has been show to reduce Th1 cell proliferation and
cytokine production such as IFN-y [118]. IL-13 is other potent immune modulator
and might contribute to the development of Th2 immune response by reducing
IL-12 production [119].

Importantly, production of those anti-inflammatory

cytokines, including IL-4, IL-10 and

TGF-~,

is reduced by age [114, 120].

All together, we think that increased inflammation by age due to
dysregulated host immune responses to microorganisms could negatively affect
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Del-1 expression. Indeed, we observed that inflammation resulted in reduced
expression of Del-1 in our ligature-induced periodontitis model and it also is
reported that Del-1 expression was regulated inflamed tissue and the endothelial
cell upon stimulated by TNF-a [52].
Another possible mechanism that could explain why we see more
inflammatory response in old mice might be changes in neutrophils' function
seen in the elderly [121]. Neutrophils are an important part of the immune
response towards invading organisms. They are the first line of defense, forming
part of the innate immune response. With aging, decreases have been recently
demonstrated in specific cell functions, such as apoptosis/survival of PMN [121].
These alterations might contribute to the increased incidence of infections with
aging. Apoptosis plays an important role in the regulation of tissue development,
differentiation and homeostasis as well as in several pathologies in chronic
inflammatory diseases [122, 123]. Mature neutrophils undergo spontaneous
apoptosis very rapidly when maintained in vitro; this sensitivity to apoptosis
regulates both their production and their survival. However, their lifespan has
been reported to be reduced by age [124], leading to the increased number of
apoptotic cells in the inflamed area. To sustain homeostasis, these apoptotic
neutrophils

are

quickly

removed

by

professional

phagocytes

such

as

macrophages [125]. The engulfment of apoptotic cells provides a benefit to the
host by preventing the inflammation and tissue damage that can be caused by
intracellular materials being released from dying cells. Thus, it is expected to
have more inflammation upon the burden of apoptotic cells exceeds the capacity
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of the macrophages. Importantly, Del-1 has been reported to bind specifically
apoptotic cells by recognizing phosphatidylserine [72]. In this study, it was clearly
shown that Del-1 can work as a bridge between apoptotic cells and phagocytes
[72]. Since macrophages are a key player to clean up apoptotic cells, it can be
questioned the number macrophage in the elderly or Del-1 deficient mice. It has
been reported that macrophage function, rather than their number, is affected by
age [126]. We also found showed that CD14 expression showed a similar
expression level in Del-1 deficient or wild type mice (data not shown). Together,
reduced engulfment of apoptotic neutrophils by macrophages could lead to
increased inflammation seen in the elderly.
We demonstrated that Del-1 is required for homeostatic inhibition of
inflammatory

periodontal

bone

loss involving

LFA-1-dependent neutrophil

recruitment and IL-17R signaling. In Del-1-1- mice, periodontitis developed
spontaneously in a chronic setting of dysregulated neutrophil recruitment without
requiring experimental intervention (e.g., superinfection with a human periodontal
pathogen or injection of bone loss-inducing agents such as lipopolysaccharide)
as often required in animal periodontitis models [91]. A phenotype comparable to
that of Del-1-1- mice was mirrored in normal old mice, in which inflammatory bone
loss increased linearly with reduced expression of Del-1.
We found that the periodontal bone loss associated with Del-1 defiCiency
was drastically (>75%) reversed in Oel-rl--LFA-rl- mice, which additionally
displayed reduced neutrophil infiltration in the gingiva as compared to Oel-rl-
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mice. Therefore, the protective role of Oel-1 against periodontitis is mediated
through regulation of LFA-1-dependent neutrophil trafficking.
Moreover, in comparison to Oe/-rl- mice, the Oe/-rl--LFA-rl- mice
displayed decreased gingival levels of IL-17 due to, at least in part, reduced
infiltration of neutrophils, which expressed IL-17. In this regard, we observed
co localization of IL-17 and Ly6G in gingival tissues of both Oel-rl- and Oel-rl--

LFA-rl-mice by immunohistochemistry. This observation is consistent with the
notion that much of the IL-17 released at sites of inflammation derives from
innate immune cells, including neutrophils [89].
The development of periodontitis was abrogated in Oel-1-1--IL-17R-1- mice
and this, to our knowledge, is the first time that IL-17R signaling is causally linked
to alveolar bone loss. Our findings are thus consistent with the elevated levels of
IL-17 in human periodontitis [4, 93-95] and in mouse periodontitis models [74,
96].

IL-17 was also shown to stimulate antimicrobial immunity and thereby to

inhibit pathogen-initiated bone loss in a relatively acute periodontitis model [97];
however, chronic IL-17R signaling can turn an acute inflammatory response into
chronic immunopathology, as seen in rheumatoid arthritis [4, 22]. In this context,
IL-17 can mediate connective tissue destruction and bone resorption efficiently
and independently of IL-1 J3 and TNF-a; the underlying mechanisms are largely
dependent on induction of matrix metalloproteases and RANKL (receptor
activator of nuclear factor-KB ligand) [22, 98]. In this regard, the Oel-r/- mice
exhibited 3-fold higher RANKL expression in the gingiva than wild-type controls,
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although

both

groups

had

similar expression

of the

RANKL

inhibitor,

osteoprotegerin.
These findings indicate that Del-1 deficiency causes periodontal bone loss
that is dependent on LFA-1-dependent neutrophil recruitment and IL-17R
signaling. Moreover, conditions that restore tissue homeostasis in terms of
periodontal

bone

maintenance

(i.e.,

dual

Del-1/LFA-1

or

Del-1I1L-17R

deficiencies) also reverse the numbers of oral bacteria to near normal levels.
Importantly, age-associated periodontal inflammation (including neutrophil
accumulation and IL-17 production) was suppressed by local administration of
Del-1. Del-1 is associated with the extracellular matrix and endothelial cell
surface but not circulated in the blood [127]. It has recently shown that Del-1 is
expressed in tissue specific-manner: very little expression in the kidney, none in
the liver and a strong expression in the eye and brain [52], suggesting that Del-1
might be a key player in a certain tissues that may face unspecified immune
response. Del-1 structure consists of five domains: repeat domains (E1, E2 and
E3), three epidermal growth factors (EGF) at its N-terminus and two discoidin
domains at its C-terminus. E2 contains RGD sequence (Arg-Gly-Asp), which
binds integrin avj33 or a5j33 (Figure 24) [128]. The discoidin domains have been
shown to be responsible for binding phosphatidyl serine-rich membranes.
However, EGF like repeats have been shown to enable Del-1 to bind integrin
[128]. Unlike many adhesion molecules, Del-1 inhibits the process of neutrophils
binding to endothelial cells, thereby blocking entrance of neutrophils into inflamed
tissues. Under normal flow physiologic conditions, addition of Del-1 to the system
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where neutrophils adhere onto immobilized ICAM-1 with activated LFA-1
suppresses the binding of neutrophils [52]. This finding implies that Del-1 may
compete with ICAM-1 for the binding to LFA-1. All together, modulation of Del-1
expression could be a candidate therapeutic strategy for autoimmune and
chronic inflammatory disease. However, the usage of Del-1 clinically would be so
costly thereby it could not be afforded. Alternatively, some companies tried to
make synthetic inhibitors or antibodies to inhibit ICAM-1/LFA-1 binding. The
ICAM-1/LFA-1 interaction can be controlled at the site of LFA-1/ICAM interaction,
the metal-ion-dependent adhesion site (MIDAS), or through binding to an
allosteric site on LFA-1 [129] that causes it to adopt a conformation that cannot
bind to ICAM-1 . For example, the LFA inhibitor (LFA878), which binds an
allosteric site on LFA-1, has been shown to inhibit the interaction between ICAM1 and LFA-1 [130]. Therefore, we used the LFA-1 inhibitor (LFA878) or Del-1 to
prevent alveolar bone resorption and found Del-1 was more protective than that
of LFA878 (data not shown). Our findings could be explained by the fact that
LFA878 is not a competitive inhibitor, unlike Del-1, its half-life is not long enough
to block the ICAM-1/LFA-1 interaction or it obviously doesn't function as much as
Del-1 does at the cellular level. It is highly possible that Del-1 could have
activities that remain undiscovered. Since it contains EGF domain (Figure 24), it
can induce a number of signaling that needs to be studied. Indeed, Del-1 has
recently shown to induce apoptosis through its EGF domains [131]. It is,
therefore, obvious that all synthetic inhibitors or antibodies, which are available
commercially, will not function like Del-1 functions.
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Immune Netw. 2009 Oct;9(5) :153-7. Epub 2009 Oct 30.

Figure 24. Showing a domain structure of Del-1 . Del-1 structure consists of five
domains : repeat domains (E1 , E2 and E3) , three epidermal growth factors (EGF)
at its N-terminus and two discoidin domains at its C-terminus. E2 contains RGD
sequence (Arg-Gly-Asp) , which binds integrin
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av~3

or

a5~3 .

Finally, our preliminary human results showed that Del-1 expression was
dramatically reduced in diseased area as compared to healthy areas. We also
found, in contrast to reduced De-1 expression, that IL-17 expression was
markedly increased in diseased areas. Those results were completely consistent
what we have found in old or Del-1 deficient mice. Del-1 could be associated with
a spectrum of age-associated diseases whose onset and course may be
influenced by pro-inflammatory cytokines. The finding that reduced Del-1
expression in old mice is capable of substantially augmenting bone loss. These
data provide important evidence of one of key mechanisms through which
reduced Del-1 expression may have potent health consequences for older adults,
accelerating risk of a host of age-related diseases.
Overall, the main conclusions could be summarized as follows:
•

Del-1 is a homeostatic regulator of chronic tissue inflammation involving
LFA-1

integrin-dependent neutrophil

recruitment

and IL-17

receptor

signaling.

•

Del-1

expression is diminished in old age leading to periodontal

inflammation and bone loss.
•

Local administration of Del-1 reverses periodontal inflammation and may
thus be a promising novel therapeutic for the treatment of periodontitis.

•

Our preliminary human data showed that Del-1 expression was higher in

healthy gingivae than diseased sites. In contrast, IL-17 expression was lower
in healthy sites than disease sites.
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Together, Del-1 inhibits LFA-1-dependent neutrophil recruitment and IL17-mediated pathology and may be a promising novel therapeutic for trating
diseases related to excessive or deficient recruitment of neutrophils. If
excessive recruitment is desired (infectious disease), a strategy to block Del-1
should be taken. In contrast, if excessive neutrohil is the issue, a strategy to
boost Del-1 should be taken.
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